The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England
暂无分享,去创建一个
[1] J. Wise. Pilot study will assess whether HPV test should replace smears to screen for cervical cancer , 2012, BMJ : British Medical Journal.
[2] S. Leeson,et al. Cervical cancer incidence in young women: a historical and geographic controlled UK regional population study , 2012, British Journal of Cancer.
[3] H. Kitchener,et al. Increasing rates of cervical cancer in young women in England: an analysis of national data 1982–2006 , 2011, British Journal of Cancer.
[4] J. Peto,et al. A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial. , 2011, European journal of cancer.
[5] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[6] K. Howard,et al. Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years , 2010, BMC public health.
[7] M. Hakama,et al. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme , 2010, BMJ : British Medical Journal.
[8] J. Cuzick,et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. , 2010, The Lancet. Oncology.
[9] Marc Arbyn,et al. The challenges of organising cervical screening programmes in the 15 old member states of the European Union. , 2009, European journal of cancer.
[10] G. Ronco,et al. Description of the national situation of cervical cancer screening in the member states of the European Union. , 2009, European journal of cancer.
[11] G. Ronco,et al. Cervical cancer screening policies and coverage in Europe. , 2009, European journal of cancer.
[12] F. Bray,et al. Trends of cervical cancer mortality in the member states of the European Union. , 2009, European journal of cancer.
[13] J. Geddes,et al. What is a randomised controlled trial? , 2009, Epidemiologia e Psichiatria Sociale.
[14] Christine J Sturrock,et al. Cervical screening in Australia 2006-2007 , 2009 .
[15] R. Legood,et al. From cost-effectiveness information to decision-making on liquid-based cytology: Mind the gap. , 2009, Health policy.
[16] B. T. Lin. Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer. , 2008, The New England journal of medicine.
[17] J. Berkhof,et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial , 2007, The Lancet.
[18] V. Beral,et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies , 2007, The Lancet.
[19] Stephen D Walter,et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. , 2007, The New England journal of medicine.
[20] J. Berkhof,et al. Risk of high‐grade cervical intra‐epithelial neoplasia based on cytology and high‐risk HPV testing at baseline and at 6‐months , 2007, International journal of cancer.
[21] V. Beral,et al. Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality , 2006, The Medical journal of Australia.
[22] Joakim Dillner,et al. Cervical carcinoma and reproductive factors: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies , 2006, International journal of cancer.
[23] V. Beral,et al. Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies , 2006, International journal of cancer.
[24] P. Boyle,et al. Chapter 11 . Statistical methods for registries , 2006 .
[25] Richard J. K. Taylor,et al. Decline in Cervical Cancer Incidence and Mortality in New South Wales in Relation to Control Activities (Australia) , 2006, Cancer Causes & Control.
[26] J. Cuzick,et al. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories , 2003, British Journal of Cancer.
[27] R. Taylor,et al. Effects of screening on cervical cancer incidence and mortality in New South Wales implied by influences of period of diagnosis and birth cohort , 2001, Journal of epidemiology and community health.
[28] J. Patnick. Cervical cancer screening in England. , 2000, European journal of cancer.
[29] P. Edwards,et al. British Medical Journal , 1876 .
[30] O. M. Jensen,et al. Cancer Registration: Principles and Methods , 1991 .
[31] D. Slater,et al. National cervical screening programme. , 1990, BMJ.
[32] Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes. , 1986, British medical journal.
[33] M. Plummer,et al. International agency for research on cancer. , 2020, Archives of pathology.
[34] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.